Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients

INTRODUCTION: Corticosteroids are one of the most promising therapeutic agents for critically ill patients with coronavirus disease 2019 (COVID-19). Despite emerging data, assessed populations and regimens vary, and there are patient subgroups whose response to steroids remains unclear. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Oganesyan, Armen, Menzulin, Ruslan, Surovoy, Yury, Nikiforchin, Andrei, Zykov, Kirill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645403/
https://www.ncbi.nlm.nih.gov/pubmed/34877019
http://dx.doi.org/10.1155/2021/5557302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645403/
https://www.ncbi.nlm.nih.gov/pubmed/34877019
http://dx.doi.org/10.1155/2021/5557302

Ejemplares similares